https://hikariq.co.jp/2021/07/31/001-jetro-award/2026-10-15T22:37:26+09:00https://hikariq.co.jp/2022/03/30/002-nikkeibio-publish/2026-10-15T22:39:24+09:00https://hikariq.co.jp/2022/04/11/003-solasia-partnership/2026-10-15T22:39:42+09:00https://hikariq.co.jp/2022/04/30/004-antibody-society/2026-10-15T22:40:09+09:00https://hikariq.co.jp/2022/06/24/005-titech-certification/2026-10-15T22:26:32+09:00https://hikariq.co.jp/2022/08/31/006-ipas-adoption/2026-10-15T22:40:56+09:00https://hikariq.co.jp/2022/08/22/007-ibody-partnership/2026-10-15T22:40:33+09:00https://hikariq.co.jp/2023/01/23/008-hikariq-obituary/2026-10-15T22:41:21+09:00https://hikariq.co.jp/2023/01/26/009-seedround-funding/2026-10-15T22:41:46+09:00https://hikariq.co.jp/2023/09/30/010-gotech-adoption/2026-10-15T22:42:10+09:00https://hikariq.co.jp/2023/11/15/011-biotechjapan-publish/2026-10-15T23:19:57+09:00https://hikariq.co.jp/2023/11/28/012-office-transfer/2026-10-15T23:21:53+09:00https://hikariq.co.jp/2023/11/28/013-antibodysociety-announcement/2026-10-15T22:43:10+09:00https://hikariq.co.jp/2024/03/25/014-license-agreement/2026-10-15T22:43:32+09:00https://hikariq.co.jp/2026/04/01/015-office-transfer/2026-10-15T23:26:02+09:00